REVIEW PAPER
Selected aspects of osteoporosis prevention
 
More details
Hide details
1
Cardiology Department with Cardiology Intensive Care Unit, Ministry of the Interior and Administration Hospital, Lublin, Poland
2
Department of Biophysics, Medical University, Lublin, Poland
CORRESPONDING AUTHOR
Magdalena Stachura   

Cardiology Department with Cardiology Intensive Care Unit, Ministry of the Interior and Administration Hospital, Grenadierów 3, 20-331 Lublin, Poland.
 
J Pre Clin Clin Res. 2008;2(1):13–18
KEYWORDS
ABSTRACT
Osteporosis affects a large percentage of postmenopausal women and leads to serious complications such as femur neck fracture. The standard of osteoporosis diagnosis is dual-energy X-ray absorptiometry (DXA) which evaluates bone mineral content and after dividing it by measurement area estimates bone mineral density. There are also biochemical indicators evaluated in human serum or urine such as calcium urine concentration, piridinoline, deoksypiridinoline (DPR), and collagene fragments, such as cross-linked N-telopeptide (NTX) and cross-linked C-telopeptide (CTX), which may be useful for determining the activity of bone formation and resorption processes. They are frequently used for scientifi c purposes, but not in general medical practice. Osteoporosis risk factors include: age over 70 years, low weight (below 40 kg) or body mass index (BMI) below 20, weight loss of more than 10% of total body mass, low physical activity, chronic treatment with glucocorticoids or anti-epileptic drugs, anorexia nervosa, type 1 diabetes mellitus, past gastrectomy, and hyperparathyroidismus. There are also some other conditions which may affect bone metabolism which include: female sex, smoking, cases of fractures in family, a history of ovariectomy, early menopause (before the age of 45), low calcium consumption, hyperthyroidismus, rheumatoid arthritis, chronic alcoholism, excessive vitamin A intake and cola drinks. Also, adequate intake of proteins and macro- and microelements may affect bone metabolism. Some epidemiological studies suggest that higher consumption of soy bean based foods in Asian populations compared to Western populations may be responsible for the low incidence of postmenopausal osteoporosis in Asian women. Soy beans are a rich source of isoflavones, mainly genistein and daidzein, which have both weak estrogenic and antiestrogenic effects. Isoflavones bind to estrogen receptors in body tissues such as uterine or bones, and some data suggest that they may stimulate osteoblastic activity and bone formation, and also inhibit osteoclastic bone resorption. In this way, they may prevent postmenopausal bone loss. The protective effects of other natural substances such as rhizome of Anemarrhena aspheloides or aqueus extract of black tea have also been investigated. This article presents a review of food contents and lifestyle factors which infl uence bone metabolism.
 
REFERENCES (30)
1.
Czerwiński E, Badurski JE, Marcinowska-Suchowierska E, Osieleniec J: Wspołczesne rozumienie osteoporozy w świetle stanowiska World Health Organization (WHO) i International Osteoporosis Foundation (IOF). Ortopedia Traumatologia Rehabilitacja 2007, 9, 337-356.
 
2.
McClung MR: The relationship between bone mineral density and fracture risk. Curr Osteoporosis Rep 2005, 3, 57-63.
 
3.
Pluskiewicz W: Lekarz rodzinny (General Practitioner). Med po Dypl wyd specj, maj 2005 (Post Grad Med special edition, May 2005).
 
4.
Tałałaj M, Marcinowska-Suchowierska E, Jasik A: Diagnostyka osteoporozy – aspekty praktyczne (Osteoporosis diagnosis – practical aspects). Med po Dypl wyd specj, maj 2004 (Post Grad Med special edition, May 2004).
 
5.
Dębski R: Estrogeny a osteoporoza (Estrogenes and osteoporosis). Med po Dypl wyd specj, maj 2004 (Post Grad Med special edition, May 2004).
 
6.
Marczyński W, Gorecki A, Czerwiński E, Chmielewski D: Zasady profi laktyki, rozpoznawania i leczenia osteoporotycznych złamań kości. Ortopedia Traumatologia Rehabilitacja 2007, 9, 548-554.
 
7.
Gala J, Diaz-Curiel M, de la Piedra C, Calero J: Short- and long-term eff ects of calcium and exercise on bone mineral density in ovariectomized rats. Br J Nutr 2001, 86, 521-527.
 
8.
McClung MR: Inhibition of RANKL as a treatment of osteoporosis: preclinical and early clinical studies. Curr Osteoporosis Rep 2006, 4, 28-33.
 
9.
Cai DJ, Zhao Y, Glassie J, Cullen D, Barnes S, Turneh ChH, Wastney M, Weaver CM: Comparative eff ect of soy protein, soy isofl avones, and 17β-estradiol on bone metabolism in adult ovariectomized mice. J Bone Min Res 2005, 20, 828-839.
 
10.
Lee YB, Lee HJ, Kim KS, Lee JY, Nam SY, Cheon SH, Sohn HS: Evaluation of the preventive eff ect of isofl avone extract on bone loss in ovariectomized rats. Biosci Biotechnol Biochem 2004, 68(5), 1040- 1045.
 
11.
Shiguemoto GE, Rossi EA, Baldissera V, Gouvela CH, Font de Valdez Vargas GM, de Andrade Perez SE: Isofl avone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Maturitas 2007, 57(3), 261-270.
 
12.
Devareddy L, Khalil DA, Smith BJ, Lucas EA, Soung DY, Marlow DD, Arjmandi BH: Soy moderately improves microstructural properties without aff ecting bone mass in an ovariectomized rat model of osteoporosis. Bone 2006, 38(5), 686-693.
 
13.
Wu J, Wang X, Chiba H, Higuchi M, Nakatani T, Ezaki O, Cui H, Yamada K, Ishimi Y: Combined intervention of soy isofl avone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 2004, 53(7), 942-948.
 
14.
Figard H, Mougin F, Gaume V, Berthelot A: Combined intervention of dietary soy bean proteins and swimmig training: eff ects on bone metabolism in ovariectomized rats. J Bone Miner Metab 2006, 24, 206-212.
 
15.
Breitman PL, Fonseca D, Cheung AM, Ward WE: Isofl avones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isofl avones alone. Bone 2003, 33(4), 597-605.
 
16.
Pie JE, Park JH, Park YH, Ryu YM, Kim KN, Suh SW, Becker KG, Cho-Chung YS, Kim MK: Eff ect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J Nutr Biochem 2006, 17(3), 157-164.
 
17.
Nakajima D, Kim ChS, Oh TW, Yang ChY, Naka T, Igawa S, Ohta F: Suppressive eff ects of genistein Osage and resistance exercise on bone loss in ovariectomized rats. J Physiol Anthropol Appl Human Sci 2001, 20(5), 285-291.
 
18.
Fonseca D, Ward WE: Daidzein together with high calcium preserve bone mass and biochemical strength at multiple sites in ovariectomized mice. Bone 2004, 35(2), 489-497.
 
19.
Mathey J, Mardon J, Fokialakis N, Puel C, Kati-Coulibaly S, Mitakou S, Bennetau-Pelissero C, Lamothe V, Davicco MJ, Lebecque P, Horcajada MN, Coxam V: Modulation of soy isofl avones bioavailability and subsequent eff ects on bone health in ovariectomised rats: the case for equol. Osteoporos Int 2004, 18(5), 671-679.
 
20.
Nian H, Qin LP, Chen WS, Zhang QY, Zheng HCh, Wang Y: Protective eff ect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats. Acta Pharmacologica Sinica. 2006, 27(6), 728-734.
 
21.
Nian H, Xu LL, Ma MH, Qin LP, Zheng HCh, Zhang QY: Prevention of bone loss by aqueous extract of Epimedii sagittatum in an ovariectomized rat model of osteoporosis. J Chin Integr Med 2006, 4(6), 628-633.
 
22.
Das AS, Das D, Mukherjee M, Mukherjee S, Mitra Ch: Phytoestrogenic eff ects of black tea extract (Camelia sinensis) in an oophorectomized rat (Rattus norvegicus) model of osteoporosis. Life Sci 2005, 77, 3049- 3057.
 
23.
Hukkanen M, Platts LA, Lawes G, Girgis SI, Kontinnen YT, Goodship AE, MacIntyre I, Polak J: Eff ect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen defi ciency-induced osteopenia. Bone 2003, 32(2), 142-149.
 
24.
Ilich JZ, Brownbill RA, Tamborini L: Bone and nutrition in elderly women: protein, energy and calcium as main determinants of bone mineral density. Eur J Clin Nutr 2006, 57, 554-565.
 
25.
Korpelainen R, Korpelainen J, Heikkinen J, Vaananen K, Keinanen- -Kiukaanniemi S: Liefestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a populationbased cohort study of 1,222 women. Osteoporos Int 2006, 14, 34-43.
 
26.
Yahata Y, Aoyagi K, Okano K, Yoshimi I, Kusano Y, Kobayashi M, Moji K, Takemoto T: Matacarpal bone mineral density, body mass index and lifestyle among postmenopausal Japanese women: relationship of body mass index, physical activity, calcium intake, alcohol and smoking to bone mineral density: the Hizen-Oshima study. Tohoku J Exp Med 2002, 196, 123-129.
 
27.
Ilich JZ, Brownbill RA, Tamborini L, Crncevic-Orlic Z: To drink or not to drink: how are alcohol, caff eine and past smoking related to Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP: Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study. Am J Clin Nutr 2006, 84(4), 936-942
 
28.
Bounds W, Skinner J, Carruth BR, Ziegler P: The relationship of dietary and lifestyle factors to bone mineral indexes in children. J Am Diet Assoc 2005, 105(5), 735-741.
 
29.
Sahin G, Polat G, Baois S, Milcan A, Baodatoolu O, Erdooan C, Camdeviren H: Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 2003, 23, 87-91.
 
30.
Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Cihara K: Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol, 2001, 55, 341- 347.
 
eISSN:1898-7516
ISSN:1898-2395